Neuropeptides in nasal mucosa.
Woodhead
C J
CJ
Department of Otolaryngology, Hull Royal Infirmary, UK.
D001920:Bradykinin / Q000187:drug effects / Q000502:physiology; D015740:Calcitonin Gene-Related Peptide / Q000187:drug effects / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D015777:Eicosanoids / Q000378:metabolism / Q000502:physiology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006801:Humans; D009297:Nasal Mucosa / Q000502:physiology*; D009298:Nasal Polyps; D015288:Neurokinin A / Q000187:drug effects / Q000502:physiology; D009478:Neuropeptide Y / Q000187:drug effects / Q000502:physiology; D010972:Platelet Activating Factor / Q000502:physiology; D018015:Receptors, Calcitonin Gene-Related Peptide / Q000502:physiology; D012220:Rhinitis; D013373:Substance P / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D014660:Vasoactive Intestinal Peptide / Q000502:physiology
D016207:Cytokines; D015777:Eicosanoids; D006634:Histamine H1 Antagonists; D009478:Neuropeptide Y; D010972:Platelet Activating Factor; D018015:Receptors, Calcitonin Gene-Related Peptide; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D015288:Neurokinin A; D015740:Calcitonin Gene-Related Peptide; D001920:Bradykinin